Shanghai Fudan Forward S&T Co., Ltd (SHANGHAI FUDAN FORWARD SCIENCE ) Aktie

Shanghai Fudan Forward S&T Co., Ltd engages in the medical and health, digital economy, high-tech, and other businesses. The company is involved in the research and development, production, and sales of computer systems, communication equipment, automation instruments, biotechnology, light source lighting, and other products; and import and export business. It also engages in the research and development, production, and sales of chemical raw materials, chemical pharmaceutical preparations, and traditional Chinese medicine; exporting software to Japan in the fintech sector; and development, construction, operation, and management of high-tech parks. In addition, the company provides investment and consulting services in the high-tech field; distributes car audio and high-end car care products; processes sheet metals; and develops health management systems. Further, it focuses on specialized drugs and specialty drugs; and digestive system drugs, nervous system drugs, anti-tumor drugs, circulatory system drugs, etc., as well as injectable glutathione, shuangyiping tablets, flutamide tablets, isosorbide dinitrate tablets, and other products. Shanghai Fudan Forward S&T Co., Ltd was founded in 1984 and is based in Shanghai, China.